1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Poland Pharmaceuticals Report - 2014

Poland Pharmaceuticals Report - 2014

  • October 2014
  • -
  • Emerging Markets Direct Media Holdings
  • -
  • 19 pages

This report covers the market developments in FY 2013 and the data available as of October 2014.



The Polish pharmaceutical market resumed growth in 2013, partly on low-base comparison, yet visibly, albeit slowly, recovering after the decline in 2012, when the entire pharma sector was affected by the price cut for reimbursed drugs, as part of the Reimbursed Act enforced and amended during the year.



The market rebound was visible in the first nine months of 2014 as well, yet for the full year results the flu season might make a difference for pharmacies considering the high base comparison in 2013. The pharmacies continue to be negatively affected by the fixed retail margins on reimbursable drugs, the frequent changes to the reimbursable drug list and the pharmacy advertising ban.



The OTC sales continued to record dynamic annual growth in 2013, partly on low base comparison, but also fuelled by high demand in the context of long winter and high incidence of seasonal infections. In January-August 2014 the OTC sales inched down marginally y/y and the full year growth pace is expected to be lower than in 2013, yet the incidence of diseases during the cold season might drive sales upwards towards the yearend.



The pharmaceutical market is expected to continue on upward path this year, but at a slower pace compared to 2013. At pharmacy retail level, the market is expected to grow by approximately 2-4% y/y, while at distributors' level the market is forecasted to grow by around 3-6% y/y in 2014, according to players' estimates.



Key points:

oPharmaceutical sales value returns to y/y growth in 2013

oMarket rebound is further visible in Jan-Sep 2014

oParallel exports surge, driven by low drug prices

oProfitability, revenues of top distributors improve y/y in 2013

oPolpharma plans investments in two production facilities

oNeuca to broaden activity range, plans developing medical clinic chain

oPelion takes over cosmetics chain Drogerie Natura

oNeuca acquires two clinic operators in July 2014, health centre later in October

Table Of Contents

Poland Pharmaceuticals Report - 2014
Contents

Executive summary4

Market overview5

Pharmaceutical sales value returns to y/y growth in 20135

Market rebound is further visible in Jan-Sep 20146

Pharmaceutical sold production value up y/y in 2013, Jan-Sep 20147

Pharma market expected to continue growing this year, at slower pace than in 20137

OTC sales record dynamic y/y growth in 2013, but decline marginally in Jan-Aug 20148

Parallel exports surge, driven by low drug prices9

Structural round-up in figures9

Producers - Operations12

Polpharma plans investments in two production facilities12

Polfa Warszawa to relocate Warsaw factory to TSSE12

Biomed-Lublin to build EUR33mn factory in MSSE12

Turkish pharma producer Monrol to build plant near Warsaw13

Medana Pharma earmarks EUR53mn for investments in production facility, RandD centre13

Celon Pharma mulls WSE debut next year13

Teva plans EUR15mn investments in extension of Krakow plant14

Producers - MandA14

Synektik acquires rights of four radiopharmaceuticals from Austrian Iasion GmbH14

Polish pharma producer Farmina acquires German peer for undisclosed amount14

Biogened sells rights of Parkinson treatment drug to Romania's Labormed Pharma14

Bayer buys three probiotic brands from Vitis Pharma, Dicofarm15

Pharmaceutical manufacturer Polfa to acquire Russian producer Biokhimik15

Distributors - Operations15

Profitability, revenues of top distributors improve y/y in 201315

Neuca increases market share in Q3/2014, maintains FY guidance16

Neuca to broaden activity range, plans developing medical clinic chain17

Pelion sees repeating 2013 financial performance challenging, but possible17

Farmacol's sales rise y/y in H1/2013, profitability deteriorates18

Distributors - MandA19

Pelion takes over cosmetics chain Drogerie Natura19

Neuca acquires two clinic operators in July 2014, health centre later in October19

Neuca finalizes acquisition of ACP Pharma's wholesale operations19



Table 1 Expenditure on reimbursed drugs in community pharmacies in 2012-2013, by type (PLN bn)6

Table 2 Best performing companies by OTC sales growth in 20139

Table 3 OTC Market in 2010-2018f- Selected indicators9

Table 4 Polish pharmaceutical market in European context- Selective indicators in 201210

Table 5 Major 10 pharmaceutical wholesalers by total operating revenue (PLN mn, latest available year)11

Table 6 Major 20 pharmaceutical producers by total operating revenue (PLN mn, latest available year)11

Table 7 Biomed Lublin S.A.- Selected financials in 2013-2014 (PLN thou)13

Table 8 Profitability ratios of top 3 pharma distributors in 2010-201316

Table 9 Neuca S.A.- Selected financials in 2012-2014 (PLN thou)17

Table 10 Pelion S.A.- Selected financials in 2012-2014 (PLN thou)18

Table 11 Farmacol S.A.- Selected financials in 2012-2014 (PLN thou)18



Figure 1 Innovative, generic drugs value share in total market in 2011-2013 (%)5

Figure 2 Pharmacy distribution market -Segmentation by type in 2013 (% in total)5

Figure 3 Pharmaceutical market value in 2009-2014f (PLN bn)6

Figure 4 Pharmaceutical market value in retail prices in 2010-2014f (PLN bn)6

Figure 5 Production volume of basic pharmaceuticals and their preparations in 2005-2013, by type (tonnes)7

Figure 6 Pharmaceutical products- Industrial production value in 2007-2014 (PLN bn)7

Figure 7 Pharmaceutical market value forecast (PLN bn, EUR bn)8

Figure 8 Pharmaceutical production in 2008-2017f ($ mn, annual)10

Figure 9 Pharmaceutical market self sufficiency in 2007-2017f ($ bn, ratio)10

Figure 10 Net sales revenues of top 3 pharma distributors in 2012-2013 (PLN bn)16

Figure 11 Net profits of top 3 pharma distributors in 2012-2013 (PLN mn)16


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.